CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-05 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +15,000 | $10.66 | $160K | 158,618 |
| 2021-05-05 | Ali-Jackson Kamil Chief Legal Officer | Sale | −14,502 | $23.97 | $348K | 144,116 |
| 2021-05-05 | Ali-Jackson Kamil Chief Legal Officer | Sale | −498 | $24.36 | $12K | 143,618 |
| 2021-05-05 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 20,416 | ||
| 2021-05-04 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +15,000 | $10.66 | $160K | 158,618 |
| 2021-05-04 | Ali-Jackson Kamil Chief Legal Officer | Sale | −13,721 | $23.61 | $324K | 144,897 |
| 2021-05-04 | Ali-Jackson Kamil Chief Legal Officer | Sale | −1,279 | $24.47 | $31K | 143,618 |
| 2021-05-04 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 35,416 | ||
| 2021-05-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +15,000 | $10.66 | $160K | 158,618 |
| 2021-05-03 | Ali-Jackson Kamil Chief Legal Officer | Sale | −10,661 | $24.46 | $261K | 147,957 |
| 2021-05-03 | Ali-Jackson Kamil Chief Legal Officer | Sale | −4,339 | $24.91 | $108K | 143,618 |
| 2021-05-03 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 50,416 | ||
| 2021-04-26 | Ruffo Frank Chief Financial Officer | Sale | −27,239 | $25.79 | $703K | 151,820 |
| 2021-04-26 | Ruffo Frank Chief Financial Officer | Sale | −100 | $26.44 | $3K | 151,720 |
| 2021-04-23 | Ruffo Frank Chief Financial Officer | Sale | −29,200 | $26.64 | $778K | 179,859 |
| 2021-04-23 | Ruffo Frank Chief Financial Officer | Sale | −800 | $27.33 | $22K | 179,059 |
| 2021-04-22 | Ruffo Frank Chief Financial Officer | Sale | −30,000 | $26.84 | $805K | 209,059 |
| 2021-04-22 | Walker Neal President and CEO | Sale | −30,000 | $26.84 | $805K | 1,192,427 |
| 2021-03-11 | Ali-Jackson Kamil Chief Legal Officer | Gift | −7,500 | 114,696 | ||
| 2021-03-02 | Gordon David N. Chief Medical Officer | Option exercise | +8,297 | 110,772 |
Page 31 of 34 · 680 trades